397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer

Authors:
  • JCJ. Carrasco
    J. Carrasco
  • DSD. Schröder
    D. Schröder
  • ISI. Sinapi
    I. Sinapi
  • ACA. De Cuyper
    A. De Cuyper
  • GBG. Beniuga
    G. Beniuga
  • SDS. Delmarcelle
    S. Delmarcelle
  • JLJ-L. van Laethem
    J-L. van Laethem
  • NHN. Huyghe
    N. Huyghe
  • IBI. Bar
    I. Bar
  • AHA. Hendlisz
    A. Hendlisz
  • KHK.M. Haustermans
    K.M. Haustermans
  • TDT. Delaunoit
    T. Delaunoit

Abstract
No abstract available